Literature DB >> 63247

Pharmacologic modulation of inflammatory mediator release by rat mast cells.

T J Sullivan, C W Parker.   

Abstract

Current knowledge of the mechanism of inflammatory mediator release from mast cells is reviewed with particular reference to the role of cyclic nucleotides and calcium and their interrelationship with one another as defined by studies in highly purified rat peritoneal mast cells. Data are presented indicating an important role for intracellular cAMP and calcium in the mediation or modulation of release, as well as evidence for a close relationship between these two regulatory systems. Releasing agents which clearly act at the level of the plasma membrane (concanavalin A and anti-IgE antibody) are shown to differ from releasing agents that may not (48/80 and the ionophore A23187) in regard to the early cellular cAMP response, dependency of the release reaction on phosphatidyl serine, and kinetics of release. Pharmacologic modulators of release are discussed; these include: PGE1 and theophylline, which raise cAMP and inhibit release; and diazoxide, adenine, and carbachol which lower cAMP and potentiate release. Adenosine was also found to enhance release with marked effects at concentrations in the low nanomolar range.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 63247      PMCID: PMC2032576     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  75 in total

1.  Ionophore mediated equilibration of calcium ion gradients in fragmented-sarcoplasmic reticulum.

Authors:  A Scarpa; G Inesi
Journal:  FEBS Lett       Date:  1972-05-15       Impact factor: 4.124

2.  The activation of adenylate cyclase. II. The postulated presence of (A) adenylate cyclase in a phospho (inhibited) form (B) a dephospho (activated) form with a cyclic adenylate stimulated membrane protein kinase.

Authors:  A Constantopoulos; V A Najjar
Journal:  Biochem Biophys Res Commun       Date:  1973-08-06       Impact factor: 3.575

3.  Cyclic nucleotides and modulation of effector systems of inflammation.

Authors:  M Kaliner; K F Austen
Journal:  Biochem Pharmacol       Date:  1974-02-15       Impact factor: 5.858

4.  Cyclic AMP content and histamine release in rat mast cells.

Authors:  A R Johnson; N C Moran; S E Mayer
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

5.  Inhibition of histamine release by histamine controlled by H2 receptor.

Authors:  L M Lichtenstein; E Gillespie
Journal:  Nature       Date:  1973-08-03       Impact factor: 49.962

6.  Dependence of histamine release from rat mast cells on adenosine triphosphate.

Authors:  T Johansen; N Chakravarty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  Histamine release from rat mast cells by dextran: effects of adrenergic agents, theophylline and other drugs.

Authors:  J H Baxter
Journal:  Proc Soc Exp Biol Med       Date:  1972-11

8.  The activation of adenylate cyclase. I. A postulated mechanism for fluoride and hormone activation of adenylate cyclase.

Authors:  V A Najjar; A Constantopoulos
Journal:  Mol Cell Biochem       Date:  1973-11-15       Impact factor: 3.396

9.  Stimulation and inhibition of histamine release from isolated rat mast cells. Dual effects of the ionophore A23187.

Authors:  B Diamant; S A Patkar
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

10.  Histamine release from human leukocytes: studies with deuterium oxide, colchicine, and cytochalasin B.

Authors:  E Gillespie; L M Lichtenstein
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

View more
  11 in total

1.  Selective release of excreted DNA sequences from phytohemagglutinin-stimulated human peripheral blood lymphocytes. Effects of trypsin and divalent cations.

Authors:  C W Distelhorst; K Cramer; J C Rogers
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  Characterization of augmentation of allergic and non-allergic histamine release by non-steroidal anti-inflammatory/analgesic agents.

Authors:  T Hearn; R J Wojnar
Journal:  Agents Actions       Date:  1981-07

3.  Surface histamine receptors in rat peritoneal mast cells. Separation of receptor-bearing cells via binding to a histamine-protein conjugate, Cell-ect.

Authors:  E Alm; G D Bloom; B A Fredriksson
Journal:  Agents Actions       Date:  1984-04

4.  Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.

Authors:  Anna Johansson; Stina Rudolfsson; Peter Hammarsten; Sofia Halin; Kristian Pietras; Jonathan Jones; Pär Stattin; Lars Egevad; Torvald Granfors; Pernilla Wikström; Anders Bergh
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

5.  Adenosine release from stimulated mast cells.

Authors:  D L Marquardt; H E Gruber; S I Wasserman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

6.  The lectin ArtinM induces recruitment of rat mast cells from the bone marrow to the peritoneal cavity.

Authors:  Patricia Andressa de Almeida Buranello; Maria Raquel Isnard Moulin; Devandir Antonio Souza; Maria Célia Jamur; Maria Cristina Roque-Barreira; Constance Oliver
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

7.  Effects of staphylococcal enterotoxin B on rodent mast cells.

Authors:  J Komisar; J Rivera; A Vega; J Tseng
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

8.  Sodium fluoride evoked histamine release from mast cells. A study of cyclic AMP levels and effects of catecholamines.

Authors:  P E Alm
Journal:  Agents Actions       Date:  1983-04

9.  The effect of 2450 MHz microwave radiation on histamine secretion by rat peritoneal mast cells.

Authors:  M J Ortner; M J Galvin
Journal:  Cell Biophys       Date:  1980-06

10.  Effect of cholera toxin on histamine release from bone marrow-derived mouse mast cells.

Authors:  H Saito; F Okajima; T F Molski; R I Sha'afi; M Ui; T Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.